These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 22122999)

  • 1. Impact of acid inhibition on esophageal mucosal injury induced by low-dose aspirin.
    Sugimoto M; Nishino M; Kodaira C; Yamade M; Uotani T; Ikuma M; Furuta T
    Digestion; 2012; 85(1):9-17. PubMed ID: 22122999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esophageal mucosal injury with low-dose aspirin and its prevention by rabeprazole.
    Sugimoto M; Nishino M; Kodaira C; Yamade M; Ikuma M; Tanaka T; Sugimura H; Hishida A; Furuta T
    J Clin Pharmacol; 2010 Mar; 50(3):320-30. PubMed ID: 19940233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive effects of lansoprazole and famotidine on gastric mucosal injury induced by low-dose aspirin in Helicobacter pylori-negative healthy volunteers.
    Nishino M; Sugimoto M; Kodaira C; Yamade M; Uotani T; Shirai N; Ikuma M; Tanaka T; Sugimura H; Hishida A; Furuta T
    J Clin Pharmacol; 2011 Jul; 51(7):1079-86. PubMed ID: 20663999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased esophageal mucosal/submucosal blood flow in patients with gastroesophageal reflux disease: normalization by treatment with a proton pump inhibitor.
    Mine S; Iida T; Tabata T; Okada Y; Tanaka Y
    J Gastroenterol Hepatol; 2008 Feb; 23(2):303-9. PubMed ID: 17725600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four-day continuous gastric pH monitoring following anti-acid secretory drug administration: cross-over test to assess the early effects.
    Suzuki T; Yamaguchi T; Odaka T; Kobayashi M; Seza A; Kouzu T; Yokosuka O
    Aliment Pharmacol Ther; 2008 Jan; 27(1):66-71. PubMed ID: 17922801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do proton pump inhibitors attenuate the effect of aspirin on platelet aggregation? A randomized crossover study.
    Adamopoulos AB; Sakizlis GN; Nasothimiou EG; Anastasopoulou I; Anastasakou E; Kotsi P; Karafoulidou A; Stergiou GS
    J Cardiovasc Pharmacol; 2009 Aug; 54(2):163-8. PubMed ID: 19568178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between low-dose aspirin-induced gastric mucosal injury and intragastric pH in healthy volunteers.
    Nishino M; Sugimoto M; Kodaira C; Yamade M; Shirai N; Ikuma M; Tanaka T; Sugimura H; Hishida A; Furuta T
    Dig Dis Sci; 2010 Jun; 55(6):1627-36. PubMed ID: 19672708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of esomeprazole and lansoprazole for control of intragastric pH in patients with symptoms of gastro-oesophageal reflux disease.
    Johnson DA; Stacy T; Ryan M; Wootton T; Willis J; Hornbuckle K; Brooks W; Doviak M
    Aliment Pharmacol Ther; 2005 Jul; 22(2):129-34. PubMed ID: 16011671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet drugs are a risk factor for esophageal mucosal injury.
    Sugimoto M; Uotani T; Nishino M; Yamade M; Sahara S; Yamada T; Osawa S; Sugimoto K; Umemura K; Watanabe H; Miyajima H; Furuta T
    Digestion; 2013; 87(4):281-9. PubMed ID: 23774797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acid control with esomeprazole and lansoprazole: a comparative dose-response study.
    Wilder-Smith C; Lind T; Lundin C; Nauclér E; Nilsson-Pieschl C; Röhss K
    Scand J Gastroenterol; 2007 Feb; 42(2):157-64. PubMed ID: 17327934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of rabeprazole alone or in combination with H2 receptor blocker on intragastric pH: a pilot study.
    Törüner M; Bektaş M; Cetinkaya H; Soykan I; Ozden A
    Turk J Gastroenterol; 2004 Dec; 15(4):225-8. PubMed ID: 16249975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of esomeprazole and rabeprazole on intragastric pH in healthy Chinese: an open, randomized crossover trial.
    Li ZS; Zhan XB; Xu GM; Cheng NN; Liao Z
    J Gastroenterol Hepatol; 2007 Jun; 22(6):815-20. PubMed ID: 17565634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide (NO)-releasing aspirin exhibits a potent esophagoprotection in experimental model of acute reflux esophagitis. Role of nitric oxide and proinflammatory cytokines.
    Pawlik M; Pajdo R; Kwiecien S; Ptak-Belowska A; Sliwowski Z; Mazurkiewicz-Janik M; Konturek SJ; Pawlik WW; Brzozowski T
    J Physiol Pharmacol; 2011 Feb; 62(1):75-86. PubMed ID: 21451212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of gastric mucosal injury induced by anti-platelet drugs by famotidine.
    Uotani T; Sugimoto M; Nishino M; Ichikawa H; Sahara S; Yamade M; Iwaizumi M; Yamada T; Osawa S; Sugimoto K; Umemura K; Watanabe H; Miyajima H; Furuta T
    J Clin Pharmacol; 2014 Aug; 54(8):858-64. PubMed ID: 24615745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of gastric pH with omeprazole magnesium 20.6 mg (Prilosec OTC) o.m. famotidine 10 mg (Pepcid AC) b.d. and famotidine 20 mg b.d. over 14 days of treatment.
    Miner PB; Allgood LD; Grender JM
    Aliment Pharmacol Ther; 2007 Jan; 25(1):103-9. PubMed ID: 17229225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of aspirin-induced gastric mucosal injury by histamine H2 receptor antagonists: a crossover endoscopic and intragastric pH study in the dog.
    Cavanagh RL; Buyniski JP; Schwartz SE
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1179-84. PubMed ID: 2891837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients.
    Giral A; Celikel CA; Ozdogan O; Tözün N; Ulusoy NB; Kalayci C
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1886-91. PubMed ID: 16336449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
    Weigt J; Kandulski A; Büsch F; Malfertheiner P
    Dig Dis; 2009; 27(1):68-73. PubMed ID: 19439964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial: intragastric acid control in patients who have Barrett's oesophagus--comparison of once- and twice-daily regimens of esomeprazole and lansoprazole.
    Spechler SJ; Barker PN; Silberg DG
    Aliment Pharmacol Ther; 2009 Jul; 30(2):138-45. PubMed ID: 19438416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of gastric mucosal injury severity with platelet function and gastric pH during low-dose aspirin treatment.
    Nishino M; Sugimoto M; Uotani T; Yamade M; Sahara S; Ichikawa H; Sugimoto K; Umemura K; Watanabe H; Miyajima H; Furuta T
    Digestion; 2013; 88(2):79-86. PubMed ID: 23941821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.